Black Diamond Therapeutics Inc – Quartals-Cashflow (NASDAQ:BDTX) | MetaTrader

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Gesamtvermögen 122.64 M176.25 M166.38 M157.73 M143.01 M Gesamtverbindlichkeiten 39.35 M34.73 M33.77 M31.58 M30.8 M Gesamtkapital 83.28 M141.52 M132.61 M126.15 M112.21 M Gesamtverbindlichkeiten und Eigenkapital 122.64 M176.25 M166.38 M157.73 M143.01 M Gesamtverschuldung ————— Nettoverschuldung —————

Nachrichten

Why Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?

BDTX and Brain Metastases: Why CNS Activity Could Matter in 2026

Black Diamond Stock: Weighing Catalysts vs. Concentration

BDTX: What Silevertinib Data Say About EGFR NSCLC Upside

Black Diamond Therapeutics: Market Yawning About Data, But I See Opportunity (BDTX)

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year?

What Makes Black Diamond (BDTX) a New Strong Buy Stock

New Strong Buy Stocks for January 9th

Down 30.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX)

Black Diamond Therapeutics: Stifel bekräftigt "Buy"-Rating nach vielversprechenden Studiendaten

Stifel reiterates Buy rating on Black Diamond Therapeutics stock at $8